Form 4: Health Catalyst CFO Jason Alger Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Jason Alger, CFO of Health Catalyst, Inc., sold 2,823 shares of common stock at a price of $6.83 per share on June 12, 2024, under a pre-arranged trading plan.
Summary
- On June 12, 2024, Jason Alger, the Chief Financial Officer of Health Catalyst, Inc. (HCAT), sold 2,823 shares of the company's common stock.
- The shares were sold at a price of $6.83 per share.
- Following the transaction, Alger directly owns 118,170 shares of Health Catalyst stock.
- The sale was executed under a pre-arranged trading plan adopted on March 13, 2024, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 03/13/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 06/12/2024 | Date of the stock sale transaction |
| 06/13/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.